XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
3.75% Convertible Senior Notes
Common Stock
5.5% Convertible Senior Notes
Common Stock
Private placement
Common Stock
Additional Paid-in-Capital
3.75% Convertible Senior Notes
Additional Paid-in-Capital
5.5% Convertible Senior Notes
Additional Paid-in-Capital
Private placement
Additional Paid-in-Capital
Accumulated Other Comprehensive Income
Treasury Stock
Accumulated Deficit
3.75% Convertible Senior Notes
5.5% Convertible Senior Notes
Private placement
Total
Balance at Dec. 31, 2019       $ 3,186       $ 1,506,953 $ 1,288 $ (31,216) $ (1,350,307)       $ 129,904
Balance (in shares) at Dec. 31, 2019       318,637,560           15,259,045          
Increase (Decrease) in Stockholders' Equity                              
Net loss attributable to the Company                     (37,432)       (37,432)
Other comprehensive loss                 (236)           (236)
Stock-based compensation       $ 2       3,051   $ (8)         3,045
Stock-based compensation (in shares)       156,416           1,962          
Stock dividend               13     (13)        
Stock dividend (in shares)       3,857                      
Stock option exercises       $ 32       6,072             6,104
Stock option exercises (in shares)       3,206,185                      
Provision for common stock warrants               2,566             2,566
Accretion of discount, preferred stock               (28)             (28)
Conversion of preferred stock       $ 2       467             469
Conversion of preferred stock (in shares)       216,451                      
Balance at Mar. 31, 2020       $ 3,222       1,519,094 1,052 $ (31,224) (1,387,752)       104,392
Balance (in shares) at Mar. 31, 2020       322,220,469           15,261,007          
Balance (Adoption of ASU 2020-06) at Dec. 31, 2020               (130,249)     9,550       (120,699)
Balance at Dec. 31, 2020       $ 4,740       3,446,650 2,451 $ (40,434) (1,946,488)       $ 1,466,919
Balance (in shares) at Dec. 31, 2020       473,977,469           15,926,068         473,977,469
Increase (Decrease) in Stockholders' Equity                              
Net loss attributable to the Company                     (60,746)       $ (60,746)
Other comprehensive loss                 (1,031)           (1,031)
Stock-based compensation               9,695             9,695
Stock-based compensation (in shares)       15,166                      
Issuance of common stock, net     $ 549 $ 322     $ 1,564,088 2,022,866           $ 1,564,637 2,023,188
Issuance of common stock, net (in shares)     54,966,188 32,200,000                      
Stock option exercises       $ 18       4,691             4,709
Stock option exercises (in shares)       1,758,375                      
Exercise of warrants       $ 163       15,282             15,445
Exercise of warrants (in shares)       16,308,978                      
Provision for common stock warrants               1,601             1,601
Conversion of Convertible Senior Notes $ 30 $ 1     $ 15,155 $ 159           $ 15,185 $ 160    
Conversion of Convertible Senior Notes (in shares) 3,016,036 69,808                          
Balance at Mar. 31, 2021       $ 5,823       $ 6,949,938 $ 1,420 $ (40,434) $ (1,997,684)       $ 4,919,063
Balance (in shares) at Mar. 31, 2021       582,312,020           15,926,068         582,312,020